Kennedy Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-117,702
Closed -$2.19M 610
2025
Q2
$2.19M Sell
117,702
-69,441
-37% -$1.38M 0.05% 431
2025
Q1
$3.59M Sell
187,143
-80,212
-30% -$2.35M 0.09% 341
2024
Q4
$9.63M Buy
267,355
+142,321
+114% +$4.81M 0.21% 143
2024
Q3
$5.3M Buy
+125,034
New +$5.3M 0.12% 302
2023
Q3
Sell
-140,704
Closed -$3.45M 713
2023
Q2
$3.45M Buy
140,704
+81,146
+136% +$2.61M 0.08% 369
2023
Q1
$2.42M Buy
59,558
+76
+0.1% +$3.15K 0.07% 377
2022
Q4
$2.67M Sell
59,482
-102,167
-63% -$4.63M 0.08% 380
2022
Q3
$7.74M Buy
161,649
+128,706
+391% +$7.06M 0.23% 149
2022
Q2
$1.95M Buy
32,943
+1,565
+5% +$128K 0.05% 417
2022
Q1
$3.65M Buy
31,378
+374
+1% +$43.7K 0.09% 366
2021
Q4
$4.67M Sell
31,004
-1,075
-3% -$145K 0.1% 363
2021
Q3
$3.83M Sell
32,079
-24,859
-44% -$2.74M 0.09% 391
2021
Q2
$5.55M Sell
56,938
-1,166
-2% -$104K 0.12% 329
2021
Q1
$5.13M Sell
58,104
-1,754
-3% -$163K 0.1% 363
2020
Q4
$5.73M Buy
59,858
+13,480
+29% +$1.39M 0.13% 301
2020
Q3
$5.26M Buy
46,378
+2,023
+5% +$213K 0.15% 260
2020
Q2
$4.39M Buy
+44,355
New +$3.54M 0.13% 311
2018
Q3
Sell
-97,771
Closed -$2.15M 768
2018
Q2
$2.15M Sell
97,771
-102,104
-51% -$1.26M 0.04% 590
2018
Q1
$991K Buy
+199,875
New +$644K 0.02% 664

Other funds holding TNDM

Kennedy Capital Management's TNDM Position: Q3 2025 in Review

Kennedy Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 117,702 shares — an estimated $2.19M sold.

Kennedy Capital Management first reported a position in TNDM in Q1 2018 and held it in 19 quarters. The position peaked at $9.63M in Q4 2024. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Kennedy Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 117,702 Tandem Diabetes Care shares in Q3 2025, an estimated $2.19M.
  • Kennedy Capital Management first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 19 quarters.
  • Kennedy Capital Management's Tandem Diabetes Care position peaked at $9.63M in Q4 2024.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.